Serum Institute of India (SII) has restarted the manufacturing of Covishield Vaccines, amid the rising number of COVID-19 cases in the country. CEO Adar Poonawalla has confirmed ‘6–7 Million doses’ to be made available in 90 days. 📰 COVID-19 Vaccine: Serum Institute of India Restarts Manufacturing Covishield Vaccines, CEO Adar Poonawalla Confirms ‘6–7 Million Doses’ To Be Available in 90 Days.
Many in the medical field have backed his assertions over serious side effects such as heart attack and stroke as others accuse Dr Aseem Malhotra of pushing “misguided and extreme fringe” views.
The Union Health Ministry last month refuted reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by the Indian Council of Medical Research and the Central Drugs Standard Control Organisation as ill-informed and erroneous.
Dr. Aseem Malhotra said that the Oxford-AstraZeneca jab was "worse" than mRNA vaccines when it came to adverse outcomes such as cardiovascular effects, heart attacks, and strokes; he called for its immediate review for suspension.
The Covid vaccine from Oxford/AstraZeneca is significantly worse than the mRNA jab from Pfizer in terms of cardiovascular effects, heart attacks, strokes and clotting issues in both younger and older adults, he said, , healthcare, pharma, Covishield